This HTML5 document contains 109 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://dx.doi.org/10.1097/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43368901
rdf:type
wikibase:Item
schema:description
naučni članak tudományos cikk научни чланак scientific article published in August 2009 2009年学术文章 scienca artikolo articolo scientifico научна статия 2009年の論文 vetenskaplig artikel مقالة علمية نشرت في أغسطس 2009 2009年學術文章 2009年學術文章 bài báo khoa học artikulong pang-agham wissenschaftlicher Artikel vitenskapelig artikkel 2009年学术文章 article scientific scientific article published in August 2009 artigo científico 2009年学术文章 наукова стаття, опублікована в серпні 2009 আগস্ট ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ tieteellinen artikkeli article scientifique мақолаи илмӣ artykuł naukowy 2009年學術文章 vitskapeleg artikkel 2009년 논문 სამეცნიერო სტატია vědecký článek 2009年學術文章 article científic artículu científicu espublizáu en 2009 wetenschappelijk artikel artikull shkencor 2009年学术文章 บทความทางวิทยาศาสตร์ научни чланак artikel ilmiah 2009年学术文章 teaduslik artikkel scientific article published in August 2009 artigo científico artículo científico publicado en 2009 articol științific vedecký článok научная статья videnskabelig artikel 2009年學術文章 2009 nî lūn-bûn bilimsel makale artigo científico 2009年学术文章 επιστημονικό άρθρο מאמר מדעי
p:P577
wds:Q43368901-5339EBC8-AF27-4C1A-BD30-B5A34F24A8A0
wdt:P577
2009-08-01T00:00:00Z
p:P2093
wds:Q43368901-09C85BAF-626D-4B6A-9C72-79F097BAA6DE wds:Q43368901-84AA9F06-9400-4E6D-A98F-04C33B4DAAC0 wds:Q43368901-7B7E82A2-33FB-4840-95D0-A218AC9738C1 wds:Q43368901-807B2ADD-A46E-4BF7-BF29-BF3DFBF80B62 wds:Q43368901-6FEF23DA-12DD-4B59-BDC7-21F4145C9467 wds:Q43368901-76EA4B9D-C3BB-4086-B7C5-B318937CE11A wds:Q43368901-ECCC1AD6-3E57-42A2-9B0D-2BA6BA3C30C5 wds:Q43368901-E3EA4BB8-BCE8-49F4-BE5B-C245517032F8 wds:Q43368901-EAF7B159-B292-4460-8693-897F48AD4395 wds:Q43368901-CB93C7DA-B100-4475-B29B-E45FBC65DA74
wdt:P2093
Cécile Fournel-Federico Mireille Mousseau Isabelle Jaisson-Hot Cyrille Colin Jean-Dominique Tigaud Laure Derain Bénédicte Poncet Jean-Philippe Jacquin Véronique Trillet-Lenoir Laurent Magaud
rdfs:label
Treatment of metastatic breast cancer: a large observational study on adherence to French prescribing guidelines and financial cost of the anti-HER2 antibody trastuzumab Treatment of metastatic breast cancer: a large observational study on adherence to French prescribing guidelines and financial cost of the anti-HER2 antibody trastuzumab
skos:prefLabel
Treatment of metastatic breast cancer: a large observational study on adherence to French prescribing guidelines and financial cost of the anti-HER2 antibody trastuzumab Treatment of metastatic breast cancer: a large observational study on adherence to French prescribing guidelines and financial cost of the anti-HER2 antibody trastuzumab
schema:name
Treatment of metastatic breast cancer: a large observational study on adherence to French prescribing guidelines and financial cost of the anti-HER2 antibody trastuzumab Treatment of metastatic breast cancer: a large observational study on adherence to French prescribing guidelines and financial cost of the anti-HER2 antibody trastuzumab
p:P50
wds:Q43368901-B9DE15D5-A8CC-4E34-9ED9-C6D4DAA541DA
wdt:P50
wd:Q89504757
p:P1476
wds:Q43368901-D8C14878-ED4A-4C30-9B1A-12AC8639F4D2
wdt:P1476
Treatment of metastatic breast cancer: a large observational study on adherence to French prescribing guidelines and financial cost of the anti-HER2 antibody trastuzumab
p:P304
wds:Q43368901-28B939AE-0433-4C7A-A803-D617852C7AE8
wdt:P304
369-374
p:P31
wds:Q43368901-DFE8D1A7-01DF-45DD-B521-E21B2129DD2B
wdt:P31
wd:Q13442814
p:P921
wds:Q43368901-6CF7D940-60C4-4FD7-A387-FC6762651966
wdt:P921
wd:Q12859063
p:P698
wds:Q43368901-87F21226-2118-499E-9F44-AEB4C064D865
wdtn:P698
n11:19381078
wdt:P698
19381078
p:P1433
wds:Q43368901-91944940-B685-4399-A58F-C9B300DAA7CC
wdt:P1433
wd:Q2886177
p:P433
wds:Q43368901-1FB77421-D3BF-4DFA-87F6-BB2CD5016440
p:P478
wds:Q43368901-FDF68016-0803-44A6-A649-9A54E16B0ECA
wdt:P433
4
wdt:P478
32
p:P356
wds:Q43368901-BA8DF31D-DE3D-4176-9008-FD49C6FA0980
wdtn:P356
n7:COC.0B013E31818C08D3
wdt:P356
10.1097/COC.0B013E31818C08D3